glp-1 drugs and cancer GLP-1 drugs may have a beneficial effect across many types of cancer

Could popular diabetes and weight-loss drugs influence blood cancer risk? GLP-1 receptor agonists—drugs like Ozempic and Wegovy—are widely prescribed for type 2 diabetes and weight loss. But a recent study by Dr

26.19

★★★★☆4.8 (126)

Researchers from Penn Medicine found that women taking GLP-1 drugs are less likely to be diagnosed with breast cancer., @drcelinegounder breaks down the study’s findings and whether the drugs caused

20.10

★★★★★4.9 (98)

The world's most popular weight-loss and diabetes drugs are linked to a powerful new possible benefit: better outcomes for cancer patients. 🔗 https://on.wsj.com/3RWiqVV A suite of four new studies suggest that people

26.69

★★★★★5.0 (157)

There's a surprising new benefit from taking GLP-1 weight loss drugs—using the medication is associated with lower breast cancer incidents, according to a published study. Latest Medical Watch Daily Digest: ( https://wgntv.com/news/medical-watch/glp-1

23.29

★★★★★4.7 (84)

GLP-1 weight loss drugs are being linked to lower breast cancer risk. Experts are optimistic about a possible breakthrough

27.26

★★★★★4.9 (203)

Could GLP-1 Drugs Reduce Obesity-Related Cancers in the Future?

29.94

★★★★★5.0 (176)

New studies find that GLP-1 drugs like Ozempic and Wegovy intended to treat diabetes and aid with weight loss may also reduce the risk of cancer spreading, improve survival rates, and even

22.31

★★★★★4.8 (132)